Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Biosensor-Fabricated Wooden Tongue Depressor Measures Glucose and Nitrite in Saliva

By HospiMedica International staff writers
Posted on 04 May 2023

Physicians often use tongue depressors to examine a patient's mouth and throat. More...

However, it is hard to imagine that this simple wooden tool could actively assess a patient's health. This idea has led to the development of an eco-friendly disposable sensor that can measure glucose levels and other biomarkers in saliva.

Researchers at National and Kapodistrian University of Athens (NKUA, Athens, Greece) have created this easy-to-produce device, which they believe could eventually help doctors diagnose various conditions. Wood is an attractive option for electronics and sensor design due to its renewable, biodegradable, and low-cost nature. However, its poor electrical conductivity poses challenges. One solution is to use wood as a passive substrate and coat it with metal and carbon-based inks. Another approach involves using high-power lasers to char specific regions of the wood, turning them into conductive graphite.

However, this complex technique requires advanced, costly instrumentation, an oxygen-free environment, and fire retardants. To create a more affordable and straightforward process, the researchers employed low-power diode lasers. These lasers have successfully been used to make polyimide-based sensors but have not previously been applied to wooden electronics and electrochemical sensors. The team utilized a portable, low-cost laser engraver to generate a pattern of conductive graphite electrodes on a wooden tongue depressor without the need for special conditions. These electrodes formed two electrochemical cells separated by lines drawn with a water-repellent permanent marker.

The biosensor was then used to quickly and simultaneously measure nitrite and glucose concentrations in artificial saliva. Nitrite can indicate oral diseases like periodontitis, while glucose can serve as a diagnostic for diabetes. The researchers suggest that these low-cost devices could be adapted to detect other saliva biomarkers and could be easily and rapidly produced on-site at medical facilities.

Related Links:
NKUA 


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A smartphone application displays a glucose concentration that was measured using the new sensor (Photo courtesy of Chuchu Chen and Yonghao Fu)

Wearable Device for Diabetics Could Replace Continuous Glucose Monitoring Systems

Monitoring blood glucose is essential for people with diabetes to prevent complications and maintain long-term health. Current continuous glucose monitoring systems require needles inserted under the skin,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.